437 related articles for article (PubMed ID: 12649306)
1. Sources and significance of plasma levels of catechols and their metabolites in humans.
Goldstein DS; Eisenhofer G; Kopin IJ
J Pharmacol Exp Ther; 2003 Jun; 305(3):800-11. PubMed ID: 12649306
[TBL] [Abstract][Full Text] [Related]
2. Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats.
Kvetnanský R; Goldstein DS; Weise VK; Holmes C; Szemeredi K; Bagdy G; Kopin IJ
J Neurochem; 1992 Jun; 58(6):2296-302. PubMed ID: 1573408
[TBL] [Abstract][Full Text] [Related]
3. Plasma dopa responses during stress: dependence on sympathoneural activity and tyrosine hydroxylation.
Kvetnansky R; Armando I; Weise VK; Holmes C; Fukuhara K; Deka-Starosta A; Kopin IJ; Goldstein DS
J Pharmacol Exp Ther; 1992 Jun; 261(3):899-909. PubMed ID: 1602395
[TBL] [Abstract][Full Text] [Related]
4. Adrenomedullary secretion of DOPA, catecholamines, catechol metabolites, and neuropeptides.
Chritton SL; Chinnow SL; Grabau C; Dousa MK; Lucas D; Roddy D; Yaksh TL; Tyce GM
J Neurochem; 1997 Dec; 69(6):2413-20. PubMed ID: 9375673
[TBL] [Abstract][Full Text] [Related]
5. Higher plasma catecholamine and metabolite levels in the early phase of nonsegmental vitiligo.
Cucchi ML; Frattini P; Santagostino G; Orecchia G
Pigment Cell Res; 2000 Feb; 13(1):28-32. PubMed ID: 10761993
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.
Eisenhofer G; Goldstein DS; Stull R; Keiser HR; Sunderland T; Murphy DL; Kopin IJ
Clin Chem; 1986 Nov; 32(11):2030-3. PubMed ID: 3096593
[TBL] [Abstract][Full Text] [Related]
7. New approaches to evaluate sympathoadrenal system activity in experiments on earth and in space.
Kvetnansky R; Noskov VB; Blazicek P; Macho L; Grigoriev AI; Goldstein DS; Kopin IJ
Acta Astronaut; 1994 Oct; 34():243-54. PubMed ID: 11540743
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of some acidic and alcoholic metabolites derived from m- and p-tyramine, octopamine and catecholamines in humans.
Karoum F; Moyer-Schwing J; Potkin SG; Wyatt RJ
Commun Psychopharmacol; 1977; 1(4):343-52. PubMed ID: 354855
[No Abstract] [Full Text] [Related]
9. Patterns of plasma levels of catechols in neurogenic orthostatic hypotension.
Goldstein DS; Polinsky RJ; Garty M; Robertson D; Brown RT; Biaggioni I; Stull R; Kopin IJ
Ann Neurol; 1989 Oct; 26(4):558-63. PubMed ID: 2510587
[TBL] [Abstract][Full Text] [Related]
10. Normal-range plasma catecholamines in patients with generalized and acrofacial vitiligo: preliminary report.
Orecchia G; Frattini P; Cucchi ML; Santagostino G
Dermatology; 1994; 189(4):350-3. PubMed ID: 7873818
[TBL] [Abstract][Full Text] [Related]
11. Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans.
Goldstein DS; Cannon RO; Quyyumi A; Chang P; Duncan M; Brush JE; Eisenhofer G
J Auton Nerv Syst; 1991 Jun; 34(1):17-35. PubMed ID: 1940014
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of catecholamines and their metabolites in relation to circulating catecholamines. Six-hour infusion of epinephrine and norepinephrine in healthy volunteers.
Moleman P; Tulen JH; Blankestijn PJ; Man in 't Veld AJ; Boomsma F
Arch Gen Psychiatry; 1992 Jul; 49(7):568-72. PubMed ID: 1627048
[TBL] [Abstract][Full Text] [Related]
13. Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats.
Kvetnanský R; Fukuhara K; Pacák K; Cizza G; Goldstein DS; Kopin IJ
Endocrinology; 1993 Sep; 133(3):1411-9. PubMed ID: 8396019
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension.
Goldstein DS; Holmes C; Sharabi Y; Brentzel S; Eisenhofer G
Neurology; 2003 Apr; 60(8):1327-32. PubMed ID: 12707437
[TBL] [Abstract][Full Text] [Related]
15. Plasma and cerebrospinal fluid neurochemical pattern in Menkes disease.
Kaler SG; Goldstein DS; Holmes C; Salerno JA; Gahl WA
Ann Neurol; 1993 Feb; 33(2):171-5. PubMed ID: 8434878
[TBL] [Abstract][Full Text] [Related]
16. Changes in urinary excretion of catecholamines and their metabolites in pediatric dental patients.
Sakuma N; Nagasaka N
ASDC J Dent Child; 1996; 63(2):118-22. PubMed ID: 8708120
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid and serum levels of dopa, catechols, and monoamine metabolites in patients with epilepsy.
Devinsky O; Emoto S; Goldstein DS; Stull R; Porter RJ; Theodore WH; Nadi NS
Epilepsia; 1992; 33(2):263-70. PubMed ID: 1547755
[TBL] [Abstract][Full Text] [Related]
18. Elevation of urinary catecholamines and their metabolites following tyrosine administration in humans.
Alonso R; Gibson CJ; Wurtman RJ; Agharanya JC; Prieto L
Biol Psychiatry; 1982 Jul; 17(7):781-90. PubMed ID: 7115832
[TBL] [Abstract][Full Text] [Related]
19. Plasma catechols in familial dysautonomia: a long-term follow-up study.
Goldstein DS; Holmes C; Axelrod FB
Neurochem Res; 2008 Sep; 33(9):1889-93. PubMed ID: 18357519
[TBL] [Abstract][Full Text] [Related]
20. Effects of a peripherally acting alpha 2-adrenoceptor antagonist (L-659,066) on hemodynamics and plasma levels of catechols in conscious rats.
Szemeredi K; Stull R; Kopin IJ; Goldstein DS
Eur J Pharmacol; 1989 Oct; 170(1-2):53-9. PubMed ID: 2575527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
